Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
Waldenstrom Macroglobulinemia
Status
OpenFund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Adriamycin
- Afinitor
- Afinitor Disperz
- Alkeran
- Amerinet Choice Cyclophosphamide
- Arzerra
- Belrapzo
- Bendeka
- Brukinsa
- Calquence
- Cladribine Novaplus
- Cyclophosphamide Novaplus
- Cytarabine
- Decadron
- Dexabliss 11-day
- Dexamethasone Intensol
- Dexamethasone Micronized
- Dexamethasone Sodium Phosphate
- Dexamethasone Therapy Pack
- Dextenza
- Dexycu
- Doxorubicin Hcl Novaplus
- Dxevo
- Everolimus
- Fludarabine Phosphate
- Fludarabine Phosphate Novaplus
- Hemady
- Hidex
- Imbruvica
- Kesimpta Sensoready Pen
- Kyprolis
- Leukeran
- Mavenclad
- Maxidex
- Melphalan
- Methotrexate Avpak
- Methotrexate Novaplus
- Methotrexate Sodium
- Ninlaro
- Otrexup
- Ozurdex
- Prednisone
- Prednisone Anhydrous
- Prednisone Intensol
- Premierpro Rx Cyclophosphamide
- Premierpro Rx Doxorubicin Hcl
- Rasuvo
- Rayos
- Reditrex
- Revlimid
- Riabni
- Rituxan
- Rituxan Hycela
- Ruxience
- Taperdex 6-day
- Taperdex 7-day
- Thalomid
- Treanda
- Truxima
- Velcade
- Venclexta
- Vincristine
- Vincristine Novaplus
- Xatmep
- Zcort
- Zortress
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of Waldenstrom Macroglobulinemia..
Grant Utilization
HealthWell estimates that patients use an average of $5,625 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Waldenstrom Macroglobulinemia
Waldenstrom macroglobulinemia (WM) is a rare, type of blood cancer that begins in the white blood cells and is a slow-growing cancer of the lymphatic system. Common symptoms of WM include weakness and fatigue, shortness of breath, swollen lymph nodes, and swollen abdomen due to an enlarged liver or spleen. WM suppresses the immune system making those living with the condition vulnerable to infections where even minor respiratory or wound infections can become serious medical events. Some people may develop complications including hyperviscosity syndrome (thickening of the blood) and cold aggulutinin disease (sensitivity to cold in the hands and feet due to thickening of the blood). Source: International Waldenstrom’s Macroglobulinemia Foundation
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
